echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Popular Keywords > Keyword List U > upadacitinib psoriatic arthritis

    upadacitinib psoriatic arthritis

    View news and stories of upadacitinib psoriatic arthritis. Echemi provides huge amount of upadacitinib psoriatic arthritis information to support you.
    • NEJM: Upadacitinib is better than adalimumab in treating psoriatic arthritis

      Time of Update: 2021-04-13
      Researchers have recently launched the SELECT-PsA 1 study to evaluate the efficacy and safety of Upadacitinib treatment in patients with psoriatic arthritis who have not responded to or are intolerant to traditional antirheumatic drug treatments. For patients with psoriatic arthritis, Upadacitinib treatment was better than placebo in terms of ACR20 response at week 12.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.